Now figuring out top class drugs ARNA, VVUS , AMRN what was wrong with those they all tanked
After approval, so guessing this will too. Since there are two analysts on this who are on sell side.The only analyst in the last 60 days who gave a price target with seel rating was cantor fitzgerald... No other analyst even mentioned anything. that tell's me now a diff story.
None of the drugs you mentioned will get to market as fast as IRWD's and none of the drugs you mentioned can virtually capture the entire market share. This one has so much potential, it's just sick. Also, 80% of physicians have already been approached by salespeople. Cha-ching $$